CD44 and breast cancer: Other BC-CSC markers and phenotypes have been described (e.g. EPCAM+CD44+CD24− phenotype [11], SOX2 [29], and ALDH1 [30]) and it would be of interest to investigate the effect of EP300 KD on these cell populations.